First Time Loading...

Pharma Mar SA
MAD:PHM

Watchlist Manager
Pharma Mar SA Logo
Pharma Mar SA
MAD:PHM
Watchlist
Price: 37.24 EUR 3.39%
Updated: May 28, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

333.9m
-2%
Assets
Growth Rates:
1 Year
-11%
3 Years
-3%
5 Years
+101%
7 Years
+54%
10 Years
+63%
141.2m
-4%
Liabilities
Growth Rates:
1 Year
-10%
3 Years
-35%
5 Years
-9%
7 Years
-15%
10 Years
+4%
192.7m
-0.4%
Equity
Growth Rates:
1 Year
-11%
3 Years
+51%
5 Years
+1 590%
7 Years
+285%
10 Years
+176%

Balance Sheet Decomposition
Pharma Mar SA

333.9m
Assets
141.2m
Liabilities
333.9m
Assets
141.2m
Liabilities
Current Assets 241.4m
Cash & Short-Term Investments 159.7m
Receivables 26.9m
Other Current Assets 54.7m
Non-Current Assets 92.5m
Long-Term Investments 5.6m
PP&E 53.7m
Intangibles 1.7m
Other Non-Current Assets 31.5m
Current Liabilities 92.3m
Accounts Payable 34.6m
Accrued Liabilities 803k
Short-Term Debt 5.3m
Other Current Liabilities 51.6m
Non-Current Liabilities 49m
Long-Term Debt 27.5m
Other Non-Current Liabilities 21.5m

Balance Sheet
Pharma Mar SA

Rotate your device to view
Balance Sheet
Currency: EUR
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
17
8
14
24
23
18
96
113
150
60
Cash
0
0
12
0
0
18
96
113
122
28
Cash Equivalents
17
8
2
24
23
0
0
0
28
32
Short-Term Investments
19
38
18
8
4
3
99
89
33
103
Total Receivables
41
42
64
35
27
19
37
79
59
48
Accounts Receivables
36
40
62
31
23
11
24
51
29
27
Other Receivables
5
2
2
5
4
8
14
28
30
21
Inventory
24
23
22
24
21
9
12
11
28
39
Other Current Assets
1
2
2
2
1
1
1
4
6
3
Total Current Assets
102
112
121
93
75
50
246
295
275
253
PP&E Net
29
31
31
31
27
26
25
31
35
48
PP&E Gross
29
31
31
31
27
26
25
31
35
48
Accumulated Depreciation
49
52
55
56
54
44
47
51
50
46
Intangible Assets
26
27
25
22
17
6
4
3
3
2
Goodwill
3
3
3
3
3
0
0
0
0
0
Note Receivable
0
0
0
2
0
0
0
0
0
0
Long-Term Investments
8
7
7
7
7
2
22
12
50
7
Other Long-Term Assets
26
33
34
33
30
41
33
28
31
31
Other Assets
3
3
3
3
3
0
0
0
0
0
Total Assets
194
N/A
212
+9%
221
+4%
188
-15%
158
-16%
125
-21%
330
+165%
368
+12%
393
+7%
341
-13%
Liabilities
Accounts Payable
29
32
39
37
35
19
21
27
27
29
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
44
29
28
26
28
31
17
14
15
15
Other Current Liabilities
9
10
20
19
9
10
57
45
55
52
Total Current Liabilities
83
71
87
83
72
60
95
86
97
96
Long-Term Debt
47
65
68
74
65
55
40
35
28
29
Deferred Income Tax
0
0
0
0
0
0
0
0
0
0
Minority Interest
4
4
4
4
4
4
0
0
0
0
Other Liabilities
5
3
18
8
3
2
93
69
45
22
Total Liabilities
130
N/A
135
+4%
169
+25%
161
-5%
136
-15%
113
-17%
228
+101%
190
-16%
170
-11%
147
-14%
Equity
Common Stock
11
11
11
11
11
11
11
11
11
11
Retained Earnings
262
0
25
51
59
70
42
121
157
142
Additional Paid In Capital
323
69
69
71
71
71
71
71
71
71
Unrealized Security Profit/Loss
0
0
0
0
0
0
0
0
0
0
Treasury Stock
9
3
3
4
2
1
21
26
16
31
Total Equity
64
N/A
77
+20%
52
-32%
27
-49%
21
-20%
11
-47%
103
+803%
178
+73%
223
+25%
193
-13%
Total Liabilities & Equity
194
N/A
212
+9%
221
+4%
188
-15%
158
-16%
125
-21%
330
+165%
368
+12%
393
+7%
341
-13%
Shares Outstanding
Common Shares Outstanding
219
221
18
18
18
18
18
18
18
18

See Also

Summary
PHM intrinsic value, competitors valuation, and company profile.
DCF Valuation
PHM stock valuation using Discount Cash Flow valuation method.
Relative Valuation
PHM stock valuation using valuation multiples.
Wall Street Estimates
PHM price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
PHM stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 141,400+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.